MetaADEDB 2.0 @ LMMD
bromfenac
(HZFGMQJYAFHESD-UHFFFAOYSA-M)
Structure
SMILES
[O-]C(=O)Cc1cccc(c1N)C(=O)c1ccc(cc1)Br.[Na+]
Molecular Formula:
C15H11BrNNaO3
Molecular Weight:
356.147
Log P:
2.1359
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
83.22
CAS Number(s):
91714-93-1; 120638-55-3
Synonym(s)
1.
bromfenac
2.
AHR-10282
3.
Duract
4.
ISV-303
5.
Xibrom
6.
bromfenac sodium
7.
sodium bromfenac
External Link(s)
MeSHC053083
PubChem Compound23693301
BindingDB50225143
ChEBI140536
CHEMBLCHEMBL751
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product packaging quantity issueFAERS: 23US FAERS
2Product storage errorFAERS: 11US FAERS
3Circumstance or information capable of leading to medication errorFAERS: 10US FAERS
4Drug prescribing errorFAERS: 9US FAERS
5Product dose omissionFAERS: 9US FAERS
6Drug dose omissionFAERS: 7US FAERS
7Extra dose administeredFAERS: 6US FAERS
8Eye irritationFAERS: 5US FAERS
9Liquid product physical issueFAERS: 5US FAERS
10Product quality issueFAERS: 5US FAERS
11Eye painFAERS: 3US FAERS
12Inappropriate schedule of drug administrationFAERS: 3US FAERS
13Incorrect drug administration durationFAERS: 3US FAERS
14Product container issueFAERS: 3US FAERS
15Product dropper issueFAERS: 3US FAERS
16Product physical consistency issueFAERS: 3US FAERS
17Burning sensationFAERS: 2US FAERS
18Corneal epithelium defectFAERS: 2US FAERS
19Incorrect dose administeredFAERS: 2US FAERS
20PainFAERS: 2US FAERS
21Poor quality drug administeredFAERS: 2US FAERS
22Poor quality product administeredFAERS: 2US FAERS
23Product administration errorFAERS: 2US FAERS
24Product gel formationFAERS: 2US FAERS
25Product leakageFAERS: 2US FAERS
26Accidental exposure to productFAERS: 1US FAERS
27Accidental overdoseFAERS: 1US FAERS
28BlepharitisFAERS: 1US FAERS
29Device defectiveFAERS: 1US FAERS
30Drug administration errorFAERS: 1US FAERS
31Drug ineffectiveFAERS: 1US FAERS
32Eye ulcerFAERS: 1US FAERS
33Facial PainFAERS: 1US FAERS
34Foreign body sensation in eyesFAERS: 1US FAERS
35HeadacheFAERS: 1US FAERS
36Inappropriate release of product for distributionFAERS: 1US FAERS
37Incorrect product administration durationFAERS: 1US FAERS
38InflammationFAERS: 1US FAERS
39KeratitisFAERS: 1US FAERS
40LaryngitisFAERS: 1US FAERS
41MalaiseFAERS: 1US FAERS
42MydriasisFAERS: 1US FAERS
43NauseaFAERS: 1US FAERS
44Peripheral swellingFAERS: 1US FAERS
45Prescription drug used without a prescriptionFAERS: 1US FAERS
46Product administered at inappropriate siteFAERS: 1US FAERS
47Product closure issueFAERS: 1US FAERS
48Product depositFAERS: 1US FAERS
49Product dispensing errorFAERS: 1US FAERS
50Product formulation issueFAERS: 1US FAERS
51Product lot number issueFAERS: 1US FAERS
52Product substitution issueFAERS: 1US FAERS
53Product use in unapproved indicationFAERS: 1US FAERS
54Suspected product contaminationFAERS: 1US FAERS
55SwellingFAERS: 1US FAERS
56Vitreous floatersFAERS: 1US FAERS
57Wrong technique in product usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.